Full Press Release Details
Unassociated Document.
GTBP
Unassociated Document
Key Takeaway: Unassociated Document
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+10%
120-day peak, hindsight
Typical move
2.4%
average across 4 past catalysts
Cash runway
~3 mo
High dilution risk